|
World-class teams…strong therapeutic expertise…high-quality services…leading-edge technologies…global infrastructure and leadership—these qualities are why PPD is at the forefront of the drug development services market.
Founded in 1985 as a one-person consulting firm by Dr. Fred Eshelman, today PPD is a $1.5 billion, 10,400-employee global contract research organization providing discovery, development and post-approval services as well as compound partnering programs. With offices in 31 countries, our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Our innovative technologies, therapeutic expertise and commitment to quality are why most of the top 50 pharmaceutical and biotechnology companies rely on us. Our focus is to help clients maximize returns on their R&D investments and accelerate the delivery of safe and effective therapeutics to patients.
For more information, visit our Web site at www.ppdi.com.
|